Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

Live Search
spaceKeycoe
placeholderSearch COE Business Services Wiki
typepage

Info

FDA is available only to eligible professional-track faculty.
For information on Faculty Development Leave (FDL), a program similar to sabbaticals and available only to tenured faculty, see Faculty Development Leave.

...

The Provost's Faculty Development Award program is intended to recognize excellence in the University’s professional-track faculty and provide resources to support their professional development. Application is open to all ranks of benefits-eligible professional-track faculty in the lecturer, instruction, practice, research, clinical faculty title series. The award provides up to $10,000 to support up to two years of the professional development opportunities and activities of each awardee. Funding can be used for summer salary, or can be split between summer salary and an operational account to be used by faculty member for purposes of research or professional development.

...

The total budget cannot exceed $10,000. See UT FDA Guidelines 2024-25.pdf . , section A.3 “Allowable Expenses for the FDA.”

...

Example 1: FDA activities across a two-year period beginning at the earliest permitted start time (May 16, 2025) following application:

Academic Year 2024-25

Academic Year 2025-26

Academic Year 2026-27

Fall

Spring

Summer

Fall

Spring

Summer

Fall

Spring

Summer

Apply

FDA starts

FDA ends

Year 1

Year 2

Example 2: FDA activities across a two-year period beginning at the latest permitted start time (May 16, 2026) following application:

Academic Year 2024-25

Academic Year 2025-26

Academic Year 2026-27

Academic Year 2027-28

Fall

Spring

Summer

Fall

Spring

Summer

Fall

Spring

Summer

Fall

Spring

Summer

Apply

FDA starts

FDA ends

Year 1

Year 2

Timeline for application year 2024-25

...

  • September 3-October 1: Application system open  

  • October 4: COE Faculty Affairs completes applicant eligibility review  

  • October 9-November 8: COE committee review of FDA applications  

  • November 9: Deadline for COE review committee to forward recommendations to Dean 

  • November 10-17: Dean review  

  • November 18: Dean sends FDA awardee recommendations to EVPP 

  • December 18: EVPP notifies awardees  

  • February 17: FDA recipients’ acceptance forms due to COE Faculty Affairs 

Eligibility

2024-25 guidelines will be posted August 1, 2024.

Faculty are encouraged to confirm their eligibility prior to applying.

...

  • Applicant is a professional-track faculty member (any rank) in the instruction, practice, clinical, research, or lecturer title series.

  • Has served as a benefits-eligible professional-track faculty member of at least 50% FTE at UT Austin in both the fall and spring terms during both 2022-23 and 2023-24.

  • Has met or exceeded expectations on their annual reviews in their two most recent years of benefits-eligible service preceding this FDA application (i.e. 2022-23 and 2023-24).

    • If applicant did not receive annual reviews in their two most recent years of benefits-eligible service, the department chair/immediate supervisor must contact EVPP Faculty Affairs to request an exception, and the exception must be approved.

  • Any previous FDA awarded to this applicant ended no later than summer 2023.

...

Application process

  1. Before applying, please carefully review the "Eligibility" and "Conditions for recipients" sections on this page.

  2. COE application process:

Responsible party

Step

Action

Applicant

1

a) Discuss the timing of the proposed FDA with their department chair. For timing options, see section 1 of COE FDA Timing and Eligibility Checklist.

b) Review all University and College eligibility requirements for the award - see FDA > Eligibility on this page.

2

Initiate and route COE FDA Timing and Eligibility Checklist:

a) Complete items I-IV of "Applicant completes" section and sign.

b) Department chair completes and signs the appropriate section of the form.

c) Applicant forwards form to COE-FacultyAffairs@austin.utexas.edu for review and completion. 

COE Faculty Affairs

3

Review COE FDA Timing and Eligibility Checklist, complete, and return to applicant. (Applicant will include completed form in their application materials.)

Applicant

4

Submit application including all requested materials through the Provost's online system prior to the deadline.   Note that extensions to the stated deadline will not be granted.

Applications must include all of the following documentation in order to be considered complete:

Provost’s Office

5

Online application system closes.

COE Faculty Affairs and & Provost’s Office

6

Review each applicant's materials and confirms confirm their eligibility in the application system.

Department chair

7

Receive an email notification that applicants are awaiting their review. Only materials from eligible applicants will be made available. 

8

Review applications online and makes recommendations.

COE FDL review committee

9

Review applications based on APS and COE policies, and sends recommendations to Dean.

Dean

10

Review applications based on COE FDA committee recommendations, and forwards final recommendations to Provost's Office.

Provost’s Office

11

Review Dean's recommendations and makes final decisions according to CSU allotment. Notifies applicants of their decision.

...

In COE, FDAs taken as summer salary will be processed by the faculty member's primary department, funded by an account designated by the Dean's Office. For 9-month faculty, this will be processed as a summer Additional Job (non-teaching) in Workday, funded by an account designated by the Dean's Office. For 12-month faculty, this will be processed either as a temporary increase in SWH for faculty appointed at fewer than 40 SWH, or as a temporary costing allocation change for faculty already appointed at 40 SWH. Upload a copy of the signed FDA acceptance form to the Workday Business Process, and in the comments, add "Approved FDA."

...